Irene Kuhn

1.3k total citations
21 papers, 1.0k citations indexed

About

Irene Kuhn is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Irene Kuhn has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Genetics. Recurrent topics in Irene Kuhn's work include Virus-based gene therapy research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Cancer Cells and Metastasis (4 papers). Irene Kuhn is often cited by papers focused on Virus-based gene therapy research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Cancer Cells and Metastasis (4 papers). Irene Kuhn collaborates with scholars based in United States, United Kingdom and France. Irene Kuhn's co-authors include Terry Hermiston, Mina J. Bissell, William H. Andrews, John Morser, Charles B. Glaser, Eric Blasko, Kirk Mclean, Saori Furuta, Longen Zhou and Yung‐Ming Jeng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Irene Kuhn

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irene Kuhn United States 14 444 383 364 146 145 21 1.0k
M Kuppuswamy United States 18 766 1.7× 232 0.6× 525 1.4× 400 2.7× 149 1.0× 27 1.5k
Robert R. Flandermeyer United States 11 602 1.4× 230 0.6× 333 0.9× 136 0.9× 150 1.0× 15 1.2k
Michelle H. Nelson United States 19 604 1.4× 747 2.0× 147 0.4× 67 0.5× 713 4.9× 35 1.6k
Barbara Aufiero United States 12 399 0.9× 187 0.5× 111 0.3× 65 0.4× 336 2.3× 13 1.0k
K. Springer United States 9 465 1.0× 192 0.5× 462 1.3× 140 1.0× 63 0.4× 14 933
Paul Mellor United Kingdom 20 478 1.1× 285 0.7× 69 0.2× 100 0.7× 133 0.9× 32 1.1k
Kirsty Moore United Kingdom 9 273 0.6× 178 0.5× 176 0.5× 359 2.5× 299 2.1× 25 1.2k
Marina Parry United Kingdom 16 382 0.9× 171 0.4× 197 0.5× 245 1.7× 101 0.7× 34 1.0k
G. Spira Israel 21 673 1.5× 208 0.5× 54 0.1× 66 0.5× 265 1.8× 49 1.5k
V L Morris Canada 18 504 1.1× 573 1.5× 150 0.4× 56 0.4× 224 1.5× 24 1.5k

Countries citing papers authored by Irene Kuhn

Since Specialization
Citations

This map shows the geographic impact of Irene Kuhn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Kuhn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Kuhn more than expected).

Fields of papers citing papers by Irene Kuhn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Kuhn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Kuhn. The network helps show where Irene Kuhn may publish in the future.

Co-authorship network of co-authors of Irene Kuhn

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Kuhn. A scholar is included among the top collaborators of Irene Kuhn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Kuhn. Irene Kuhn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuhn, Irene, Maxine Bauzon, Nicola Green, et al.. (2016). OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution. Molecular Therapy — Oncolytics. 4. 55–66. 17 indexed citations
2.
Hines, William C., Irene Kuhn, James C. Garbe, et al.. (2015). 184AA3: a xenograft model of ER+ breast adenocarcinoma. Breast Cancer Research and Treatment. 155(1). 37–52. 7 indexed citations
3.
Hines, William C., et al.. (2014). Sorting Out the FACS: A Devil in the Details. Cell Reports. 6(5). 779–781. 62 indexed citations
4.
Becker-Weimann, Sabine, Gaofeng Xiong, Saori Furuta, et al.. (2013). NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals. Oncotarget. 4(11). 2010–2020. 38 indexed citations
5.
Kim, Jiyoung, René Villadsen, Thérese Sørlie, et al.. (2012). Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proceedings of the National Academy of Sciences. 109(16). 6124–6129. 95 indexed citations
6.
Furuta, Saori, Yung‐Ming Jeng, Longen Zhou, et al.. (2011). Supplementary Materials for IL-25 Causes Apoptosis of IL-25R-Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells. 14 indexed citations
7.
Furuta, Saori, Yung‐Ming Jeng, Longen Zhou, et al.. (2011). IL-25 Causes Apoptosis of IL-25R–Expressing Breast Cancer Cells Without Toxicity to Nonmalignant Cells. Science Translational Medicine. 3(78). 78ra31–78ra31. 95 indexed citations
8.
Brownfield, Douglas, James C. Garbe, Irene Kuhn, et al.. (2011). Self-organization is a dynamic and lineage-intrinsic property of mammary epithelial cells. Proceedings of the National Academy of Sciences. 108(8). 3264–3269. 43 indexed citations
9.
Kuhn, Irene, Paul Harden, Maxine Bauzon, et al.. (2008). Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer. PLoS ONE. 3(6). e2409–e2409. 153 indexed citations
11.
Hermiston, Terry & Irene Kuhn. (2002). Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes. Cancer Gene Therapy. 9(12). 1022–1035. 110 indexed citations
12.
Kuhn, Irene, Marty F. Bartholdi, Hugh Salamon, et al.. (2001). Identification of AKT-regulated genes in inducible MERAkt cells. Physiological Genomics. 7(2). 105–114. 18 indexed citations
13.
Glaser, Charles B., John Morser, Eric Blasko, et al.. (1992). Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation.. Journal of Clinical Investigation. 90(6). 2565–2573. 208 indexed citations
14.
Parkinson, John F., et al.. (1992). Structure-function studies of the epidermal growth factor domains of human thrombomodulin. Biochemical and Biophysical Research Communications. 185(2). 567–576. 30 indexed citations
15.
Kiény, Marie Paule, Cécile Gautier, Catherine Tomasetto, et al.. (1990). Vaccination against polyoma virus (PYV) tumors using vaccinia‐PYV recombinants: A major tumor‐specific transplantation antigen (TSTA) epitope resides within the C‐terminal segment of middle‐T protein. International Journal of Cancer. 45(1). 185–189. 5 indexed citations
16.
Kuhn, Irene, Leland S. Paul, Jeffrey D. Gabe, et al.. (1988). Characterization of a surface antigen of Eimeria tenella sporozoites and synthesis from a cloned cDNA in Escherichia coli. Molecular and Biochemical Parasitology. 28(3). 235–247. 54 indexed citations
17.
Kuhn, Irene, et al.. (1988). Plasmid Positive Selection Vectors. Elsevier eBooks. 10. 131–152. 5 indexed citations
18.
Kuhn, Irene, et al.. (1986). Positive-selection vectors utilizing lethality of the EcoRI endonuclease. Gene. 42(3). 253–263. 48 indexed citations
19.
Hubálek, Zdeněk, et al.. (1986). Arbovirological survey in Silica plateau area, Roznava District, Czechoslovakia.. PubMed. 30(1). 87–98. 12 indexed citations
20.
Kuhn, Irene. (1980). Stage-specific antigens of Physarum polycephalum. Experimental Cell Research. 127(2). 431–434. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026